rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
1998-9-18
|
pubmed:abstractText |
Recent data suggest that interferon therapy (IFN) can reduce the risk of progression to hepatocellular carcinoma (HCC) in patients with hepatitis C virus (HCV)-related cirrhosis.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0008-543X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
83
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
901-9
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9731893-Adult,
pubmed-meshheading:9731893-Aged,
pubmed-meshheading:9731893-Carcinoma, Hepatocellular,
pubmed-meshheading:9731893-Female,
pubmed-meshheading:9731893-Hepatitis C,
pubmed-meshheading:9731893-Humans,
pubmed-meshheading:9731893-Interferons,
pubmed-meshheading:9731893-Liver Cirrhosis,
pubmed-meshheading:9731893-Liver Neoplasms,
pubmed-meshheading:9731893-Male,
pubmed-meshheading:9731893-Middle Aged,
pubmed-meshheading:9731893-Retrospective Studies,
pubmed-meshheading:9731893-Treatment Outcome
|
pubmed:year |
1998
|
pubmed:articleTitle |
Retrospective analysis of the effect of interferon therapy on the clinical outcome of patients with viral cirrhosis.
|
pubmed:affiliation |
Department of Clinical and Experimental Medicine, University of Padova, Italy.
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|